Aspirin-sensitive asthma

Internal Medicine Journal

Volumn 35, Issue 4, 2005, Pages 240-246

  Morwood, Karen ^a   Gillis, D ^b   Smith, W ^c   Kette, F ^c  

^a QUEENSLAND HEALTH   (Australia)

^b INSTITUTE OF MEDICAL AND VETERINARY SCIENCE   (Australia)

^c ROYAL ADELAIDE HOSPITAL   (Australia)

Author keywords

Aspirin desensitization; Aspirin sensitivity; Asthma; Nasal polyposis; Samter's triad

Indexed keywords

ACETYLSALICYLIC ACID; BENZYDAMINE; DICLOFENAC; DIFLUNISAL; IBUPROFEN; INDOMETACIN; KETOPROFEN; KETOROLAC; MEFENAMIC ACID; MELOXICAM; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; PEPTIDOLEUKOTRIENE; PHENYLBUTAZONE; PIROXICAM; PROSTAGLANDIN SYNTHASE; ROXITHROMYCIN; SULINDAC; TENOXICAM; TIAPROFENIC ACID;

ASTHMA; CLINICAL FEATURE; DESENSITIZATION; DIAGNOSTIC TEST; DRUG SENSITIVITY; EOSINOPHILIA; HUMAN; MAST CELL; NOSE POLYP; PATHOGENESIS; PRIORITY JOURNAL; PROVOCATION TEST; QUALITY OF LIFE; REVIEW; RHINOSINUSITIS;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASPIRIN; ASTHMA; HUMANS;

EID: 17244382915     PISSN: 14440903     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1445-5994.2004.00801.x     Document Type: Review

References (60)

1. Kohl F. A pharmaceutical of the century will be 100. A historical vignette on the introduction of acetylsalicylic acid to the market in 1899. Schmerz 1999; 13: 341-6.
2. Knox AJ. How prevalent is aspirin induced asthma? Thorax 2002; 57: 565-6.
3. Widal MF, Abrami P, Lermeyez J. Anaphylaxie et idiosyncrasies. Presse Med 1922; 30: 189-92.
4. Samter M, Beers RF Jr. Intolerance to aspirin. Clinical studies and consideration of its pathogenesis. Ann Intern Med 1968; 68: 75-83.
5. Vally H, Taylor ML, Thompson PJ. The prevalence of aspirin intolerant asthma (AIA) in Australian asthmatic patients. Thorax 2002; 57: 569-74.
6. Hedman J, Kaprio J, Poussa T, Neiminen M. Prevalence of asthma, aspirin intolerance, nasal polyposis and chronic obstructive pulmonary disease in a population based study. Im J Epidemiol 1999; 28: 717-22.
7. Kasper L, Sladek K, Duplaga M, Bochenek G, Leibhart J, Gladysz U et al. Prevalence of asthma with aspirin sensitivity in the adult population of Poland. Allergy 2003; 58: 1064-6.
8. Szczeklik A, Nizankowska E. Clinical features and diagnosis of aspirin induced asthma. Thorax 2000; 55 (Suppl 2): S42-4.
9. Stevenson DD. The American experience with aspirin desensitization for aspirin-sensitive rhinosinusitis and asthma. Allergy Proc 1992; 13: 185-92.
10. Settipane GA, Ghafee FH. Nasal polyps in asthma and rhinitis. A review of 6037 patients. J Allergy Clin Immunol 1977; 59: 17-21.
11. Szczeklik A, Nizankowska E, Duplaga M. Natural history of aspirin induced asthma. AIANE Investigators. European network on aspirin induced asthma. Eur Respir J 2000; 16: 432-6.
12. Berges-Gimeno MP, Simon RA, Stevenson DD. The natural history and clinical characteristics of aspirin exacerbated respiratory disease. Ann Allergy Asthma Immunol 2002; 89: 474-8.
13. Marquette CH, Saulnier F, Leroy O, Wallaert B, Chopin C, Demarq JM et al. Long-term prognosis for near fatal asthma. A 6 year follow up study of 145 asthmatic patients who underwent mechanical ventilation for near fatal asthma. Am Rev Respir Dis 1992; 146: 76-81.
14. Settipane GA, Klein DE, Settipane RJ. Nasal polyps, state of the art. Rhinology 1991; 11 (Suppl): 33-6.
15. Szczeklik A, Stevenson DD. Aspirin induced asthma: advances in pathogenesis, diagnosis and management. J Allergy Clin Immunol 2002; 111: 913-21.
16. Nasser SMS, Poster R, Christie PE, Sousa AR, Barker J, Schmitz-Schumann M et al. Inflammatory cell populations in bronchial biopsies for aspirin-sensitive asthmatic subjects. Am J Respir Crit Care Med 1996; 153: 90-6.
17. Cowburn AS, Sladek K, Soja A, Adamek L, Nizankowska E, Szczeklik A et al. Overexpression of leukotriene C4 synthetase in bronchial biopsies from patients with aspirin intolerant asthma. J Clin Invest 1998; 101: 1-13.
18. Bochenek G, Nagraba K, Nizankowska E, Szczeklik A. A controlled study of 9α11β-PGF2 (a prostaglandin D2 metabolite) in plasma and urine of patients with bronchial asthma and healthy controls after aspirin challenge. J Allergy Clin Immunol 2003; 111: 743-9.
19. Warner T, Mitchell J. Cyclo-oxygenase 3: filling the gaps toward a COX continuum. Proc Natl Acad Sci USA 2002; 99: 13371-3.
20. Vane JR. Aspirin and other anti-inflammatory drugs. Thorax 2000; 55 (Suppl): 53-9.
21. Szczeklik A. The cycloxygenase theory of aspirin induced asthma. Eur Respir J 1990; 3: 588-93.
22. Szczeklik A, Gryglewski RJ, Czerniawska-Mysik G. Relationship of inhibition of prostaglandin induced biosynthesis by analgesics to asthma attacks in aspirin-sensitive patients. BMJ 1975; 1: 67-9.
23. Sestini P, Armetti L, Gambaro G, Pieroni MG, Refini RM, Sala A et al. Inhaled PGE2 prevents aspirin induced bronchospasm and urinary LTE4 excretion in aspirin-sensitive asthmatics. Am J Respir Crit Care Med 1999; 153: 573-5.
24. Picado C, Fernandez-Morata JC, Juan M, Roca-Ferrer J, Fuentes M, Xaubet A et al. Cyclooxygenase 2 mRNA is down expressed in nasal polyps from aspirin-sensitive asthmatics. Am J Resp Crit Care Med 1999; 160: 291-6.
25. Sousa AR, Pfister R, Christie PE, Lane SJ, Nasser SM, Schmitz-Schumann M et al. Enhanced expression of cyclooxygenase 2 (COX2) in asthmatic airways and its cellular distribution in aspirin-sensitive asthma. Thorax 1997; 52: 940-5.
26. Sladek K, Dworski R, Soja J, Sheller JR, Nizankowska E, Oate JA et al. Eicosanoids in bronchoalveolar lavage fluid of aspirin intolerant patients with asthma after aspirin challenge. Am J Respir Crit Care Med 1994; 154: 1608-14.
27. Picado C, Ramis I, Rosello J, Prat J, Bulbena O, Plaza V et al Release of peptide leukotiene into nasal secretions after local instillation of aspirin-sensitive asthmatic patients. Am Rev Respir Dis 1992; 145: 65-9.
28. Smith CM, Hawksworth RJ, Thein FC, Christie PE, Lee TH. Urinary leukotriene E4 in bronchial asthma. Eur Respir J 1992; 5: 693-9.
29. Antczak A, Monuschi P, Kharetonow S, Gorski P, Barnes PJ. Increased exhaled cysteinyl leukotrienes and 8-isoprostane in aspirin induced asthma. Am J Respir Crit Care Med 2002; 166: 301-6.
30. Szczeklik A, Sladek K, Dworski R, Nizankowski E, Soja J, Sheller J et al. Bronchial aspirin challenge causes specific eixosanoid response in aspirin-sensitive asthmatics. Am J Crit Care Med 1996; 154: 1608-14.
31. Sousa A, Parikh A, Scadding G, Corrigan C, Lee T. Leukotriene-receptor expression on nasal mucosal inflammatory cells in aspirin-sensitive rhinosinusitis. N Engl J Med 2002; 347: 1493-8.
32. Cowburn A, Sladek K, Adamek L, Nizankowski E, Szczeklik A et al. Overexpression of leukotriene C4 synthetase in bronchial biopsies from aspirin intolerant asthmatic patients. J Clin Invest 1998; 101: 834-46.
33. Sampson NP, Cowburn AS, Sladek K, Adamek L, Nizankowska E, Szczeklik A et al. Profound overexpression of leukotriene C4 synthetase in bronchial biopsies from aspirin intolerant asthmatic patients. Int Arch Allergy Immunol 1997; 113: 355-7.
34. Sanak M, Pierzchalska M, Bazan-Socha S, Szczeklik A. Enhanced expression of the leukotriene C4 synthase due to overactive transcription of an allelic variant associated with aspirin-intolerant asthma. Am J Respir Cell Mol Biol 2000; 23: 290-6.
35. Kawagishi Y, Mita H, Taniguci M, Maruyama M, Oosaki R, Higashi N. Leukotriene C4 synthetase promotor polymorphism in Japanese patients with aspirin induced asthma. J Allergy Clin Immunol 2002; 109: 936-42.
36. Van Sambeek R, Stevenson D, Baldasaro M, Lam BK, Zhao J, Yoshida S et al. 5′ Flanking region polymorphism of the gene encoding leukotriene C4 synthase does not correlate with the aspirin-intolerant asthma phenotype in the United States. J Allergy Clin Immunol 2000; 106: 72-6.
37. Dahlen SE, Malmstrom K, Nizankowska E, Dahlen B, Kuna P, Kowalski M. Improvement of aspirin intolerant asthma by montelukast, a leukotriene antagonist, a randomized double blind placebo controlled trial. Am J Resp Crit Care Med 2002; 165: 9-14.
38. Szczeklik A, Stevenson DD. Aspirin induced asthma: advances in pathogenesis and management. J Allergy Clin Immunol 1999; 104: 5-13.
39. Nizankowska E, Duplaga M, Bochenek G, Szczeklik A. Clinical course of aspirin-induced asthma: results of AIANE. In: Szczklik A, Gryglewski R, Vane J, eds. Eicosanoids, Aspirin and Asthma. New York: Marcel Dekker; 1998; 451-71.
40. Szczeklik A, Gryglewski R, Czerniawska-Mysik G. Relationship of inhibition of prostaglandin biosynthesis by analgesics to asthma attacks in aspirin-sensitive patients. BMJ 1975; 1: 67-9.
41. Stevenson DD, Simon RA. Sensitivity to aspirin and nonsteroidal anti-inflammatory drugs. In: Middleton E, Reed CE, Ellis EF, Adkinson NF, Yunginger J, eds. Allergy: Principle and Practice, Vol. 2. St Louis, MO: Mosby-Year Book; 1993; 1747-65.
42. Melillo G, Balzano G, Bianco S, Dahlen B, Godard PH, Kowalsky ML. Oral and inhalation provocation tests for the diagnosis of aspirin-induced asthma. Allergy 2001; 56: 899-911.
43. Dahlen B, Zetterstrom O. Comparison of bronchial and per oral provocation with aspirin in aspirin-sensitive asthmatics. Eur Respir J 1990; 3: 527-34.
44. Nizankowska E, Bestynska-Krypel A, Cmiel A, Szczeklik A. Oral and bronchial provocation tests with aspirin for diagnosis or aspirin induced asthma. Eur Respir J 2000; 15: 863-9.
45. Milewski M, Mastalerz L, Nizankowska E, Szczeklik A. Nasal provocation test with lysine aspirin for diagnosis of aspirin-sensitive asthma. J Allergy Clin Immunol 1998; 101: 581-6.
46. Berges-Gimeno MP, Simon RA, Stevenson DD. The effect of leukotriene modifier drugs on aspirin-induced asthma and rhinitis reactions. Clin Exp Allergy 2002; 32: 1491-6.
47. Woessner KM, Simon RA, Stevenson DD. The safety of Celecoxib in patients with aspirin-sensitive asthma. Arthritis Rheum 2002; 46: 2201-6.
48. Gyllfors P, Bochenek G, Overholt J, Doupka D, Kumlin M, Sheller J et al. Biochemical and clinical evidence that aspirin intolerant subjects tolerate cyclo-oxygenase 2 selective analgetic drug Celecoxib. J Allergy Clin Immunol 2003; 111: 1116-21.
49. Stevenson DD, Simon RA. Lack of cross reactivity between Rofecoxib and aspirin-sensitive patients with asthma. J Allergy Clin Immunol 2001; 108: 47-51.
50. Valero A, Baltasar M, Enrique E, Pau L, Dordal T, Cistero E et al. NSAID sensitive patients tolerated Rofecoxib. Allergy 2002; 57: 1214-15.
51. Settipane RA, Schrank PJ, Simon RA, Mathieson DA, Christiansen SC, Stevenson DD. Prevalence of cross sensitivity with acetaminophen in aspirin-sensitive asthmatic subjects. J Allergy Clin Immunol 1995; 96: 480-5.
52. Stevenson DD, Pleskow WW, Simon RA, Mathieson DA, Lumry WR, Schatz M et al. Aspirin-sensitive rhinosinusitis asthma: a double blind cross over study of treatment with aspirin. J Allergy Clin Immunol 1984; 73: 500-7.
53. Sweet JM, Stevenson DD, Simon RA, Mathieson DA. Long-term effects of aspirin desensitization - treatment for aspirin-sensitive rhinosinusitis-asthma. J Allergy Clin Immunol 1990; 85 (part 1): 59-65.
54. Berges-Gimeno M, Simon RA, Stevenson DD. Long-term treatment with aspirin desensitization in asthmatic patients with aspirin exacerbated respiratory disease. J Allergy Clin Immunol 2003; 111: 180-6.
55. 5 Stevenson DD, Hankammer MA, Mathison DA, Christiansen SC, Simon RA. Aspirin desensitization treatment of aspirin-sensitive patients with rhinosinusitis - asthma: long term outcomes. J Allergy Clin Immunol 1996; 98: 751-8.
56. Wasiak W, Szmidt M. A six week double blind, placebo controlled, cross over study of the effect of misoprostol in the treatment of aspirin-sensitive asthma. Thorax 1999; 54: 900-4.
57. Shoji T, Yoshida S, Sakamoto H, Hasegawa H, Nakagawa H, Amayasu H. Anti-inflammatory effect of roxithromycin in patients with aspirin-intolerant asthma. Clin Exp Allergy 1999; 29: 950-6.
58. Ragab S, Parikh A, Darby YC, Scadding GK. An open audit of montelukast; a leukotriene receptor antagonist in nasal polyposis associated with asthma. Clin Exp Allergy 2001; 31: 1385-91.
59. Blomquist EH, Lundbland L, Anggard A, Haraldsson PO, Stjarne P. A randomized controlled study evaluating medical treatment versus surgical treatment in addition to medical treatment of nasal polyposis. J Allergy Clin Immunol 2001; 107: 224-8.
60. Hosemann W. Surgical treatment of nasal polyposis in patients with aspirin intolerance. Thorax 2000; 55 (Suppl 2): 587-90.